Assembly biosciences, inc. (ASMB)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Collaboration revenue

16,159

15,963

15,482

14,469

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Collaboration revenue

-

-

-

-

-

-

-

-

0

-

5,703

3,043

684

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating expenses:
Research and development

86,099

85,757

84,391

81,764

80,904

72,741

62,086

53,907

48,192

44,225

42,250

40,154

35,548

33,093

29,696

25,493

22,642

18,357

16,107

15,149

11,577

10,716

12,899

12,980

15,393

15,029

12,612

13,047

15,700

19,514

34,312

33,791

30,729

25,277

7,930

4,784

0

0

0

General and administrative

32,131

32,919

30,891

30,155

38,619

34,798

30,990

27,419

18,676

17,021

15,267

13,933

13,066

12,185

11,890

11,536

11,087

11,297

11,656

16,547

15,472

13,239

10,866

4,662

4,552

4,575

4,715

4,717

4,733

5,341

5,613

6,310

8,795

8,724

7,693

5,953

0

0

0

Total operating expenses

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total operating expenses

-

-

115,282

111,919

-

-

93,077

81,326

66,868

-

57,518

54,087

48,615

45,278

41,586

37,029

33,729

29,655

27,764

31,697

27,049

23,956

22,604

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Loss from operations

-102,071

-102,713

-100,351

-96,933

-104,399

-92,735

-78,692

-68,567

-54,969

-52,227

-51,815

-51,043

-47,930

-45,278

-41,586

-37,029

-33,729

-29,655

-27,764

-31,697

-27,049

-23,956

-23,765

-17,643

-19,945

-19,604

-17,327

-17,764

-20,434

-24,855

-39,926

-40,102

-39,525

-34,002

-15,624

-10,738

0

0

0

Other income
Interest and other income, net

4,062

4,300

4,510

4,643

3,914

3,083

2,380

1,505

1,292

983

843

980

1,185

1,539

1,770

1,894

1,660

1,228

827

360

185

167

163

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Other income (expense), net

-

-

-

0

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Realized loss from marketable securities

-

-

-

-

-

-

-

-

-

-

-1,099

-1,273

-1,075

-

-646

-371

-228

-27

1

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Beneficial conversion feature

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

-

0

-

-

-

-

Amortization of debt discount and warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

253

277

302

882

1,414

0

0

0

Interest expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

30

72

0

-

0

0

-

0

-

Total other income

4,067

4,305

4,746

4,797

3,937

3,083

2,110

1,218

791

368

-255

-293

109

399

1,123

1,522

1,432

1,201

829

360

185

167

163

0

0

-

0

-

-

65

0

0

0

-

-

-

0

-

-

Loss before income taxes

-98,004

-98,408

-95,605

-92,136

-100,462

-89,652

-76,937

-69,065

0

-

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Income tax benefit

-

-774

1,106

1,115

1,092

1,099

-75

-139

0

-

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

143

94

65

67

81

79

76

48

21

0

0

0

Interest Expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

Net loss

-97,237

-97,634

-96,711

-93,251

-101,554

-90,751

-67,597

-58,334

-45,127

-42,809

-51,347

-50,649

-47,203

-44,261

-40,463

-35,506

-32,297

-28,453

-26,934

-31,337

-26,863

-23,788

-23,606

-17,467

-19,750

-19,403

-17,147

-17,621

-20,339

-24,790

-39,858

-40,304

-39,796

-34,344

-17,261

-13,588

0

0

0

Other comprehensive (loss) income
Unrealized loss recognized in accumulated other comprehensive loss before reclassification, net of tax benefit of $50,664, $31,844, $44,192 and $89,281, respectively

153

146

150

185

220

45

389

321

203

209

710

490

289

221

-381

23

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Reclassification adjustment of unrealized loss included in net loss, net of tax expense of $56,139, $37,987, $56,139 and $221,358, respectively

-

-

-

-

-

-

-

-

-

-

440

653

638

-

616

342

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Unrealized gain on marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comprehensive loss

-97,084

-97,488

-96,561

-93,066

-101,334

-90,706

-67,563

-58,308

-45,061

-42,600

-50,899

-50,208

-46,978

-44,040

-40,911

-36,212

-33,046

-29,275

-32,113

-27,711

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss per share, basic and diluted

-0.76

-0.99

-0.96

-0.72

-1.05

-1.01

-0.87

-1.30

-0.80

-0.11

-0.71

-0.78

-0.81

-0.67

-0.67

-0.59

-0.64

-0.38

-0.38

-0.41

-0.64

-0.63

-1.33

-0.52

-0.92

-2.35

-1.23

-1.20

-0.22

-0.28

-0.41

-0.59

-0.66

-1.72

-0.50

-0.97

-0.38

-3.97

-4.76

Weighted average common shares outstanding, basic and diluted

35,079

27,713

25,912

25,740

25,668

25,554

24,878

20,541

20,231

19,023

17,367

17,342

17,268

17,228

17,225

17,225

17,225

17,308

17,205

17,119

11,176

10,594

8,277

4,704

4,418

-9,464

3,978

3,944

17,055

12,936

12,933

12,627

12,408

12,514

11,616

7,176

7,147

447

447